Clinical Trials Browser

Phase 2 × Unknown × nilotinib × Clear all

NCT04578847 2020-10-08

READIT

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01690065 2016-05-11

NICE-BORA

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT01168050 2011-02-08

NILOMEL

Phase 2 Unknown

Melanoma